| |
 |
Ardian has developed tools for the treatment of hypertension.
The company was acquired by Medtronic in January 2011. Ardian |
 |
Biomimedica is pioneering new approaches to joint repair through a proprietary synthetic cartilage technology. |
 |
Cianna Medical was formed to develop medical devices for
delivery of conformal radiation therapy to breast cancer
patients treated by lumpectomy. Cianna Medical. |
 |
Crux Biomedical is developing an improved, retrievable,
implantable, vena cava filter to prevent the occurrence of
pulmonary embolisms. Crux Biomedical |
 |
CyberHeart was formed to develop radiosurgery technologies to
treat cardiac arrhythmia's, including atrial fibrillation, on a
minimally invasive basis. CyberHeart |
|
CytoPherx is a clinical stage medical device company addressing inflammation-based diseases and conditions
with a proprietary selective Cytopheresis system.
CytoPherx |
 |
Evalve has developed devices to enable percutaneous repair of cardiac valves. The Company was acquired by Abbott Vascular in October 2009. |
|
Figure 8 Surgical is developing improved sternum closure
devices.
Figure 8 Surgical |
|
Focal Therapeutics was founded to develop novel tissue
marking devices to be used in surgery.
Focal Therapeutics |
|
HeartFlow’s FFRCT analysis uses the power of high performance computing and image data from CT scans to provide physicians
with data about blood flow within the coronary arteries. Their technology enables the determination of FFR in a non-invasive manner.
HeartFlow |
 |
Hemosphere is developing a device to for long-term subcutaneous
AV access for access-challenged hemodialysis patients. Hemosphere |
 |
ImaCor is developing solutions for assessing and monitoring
cardiac function in hemodynamically unstable patients. ImaCor |
 |
Incline Therapeutics has developed IONSYSTM (fentanyl iontophoretic transdermal system), an investigational product candidate intended to provide patient-controlled analgesia for adult in-hospital patients requiring opioids following surgery. Incline Therapeutics |
 |
InSite Medical Technologies was established to develop devices to simplify epidural access. InSite Medical Technologies |
 |
Intuity Medical is developing POGOTM, the first All-in-OneTM
blood glucose monitoring system. Intuity Medical |
 |
Nanostim is developing miniaturized cardiac rhythm devices. |
 |
Niveus Medical is developing a self-calibrating electrical stimulation product which stimulates muscle contraction during extended periods of critical care. |
 |
Novare was formed to develop innovative devices for minimally invasive surgery, specifically laparoscopic surgery. The company was sold in 2011. |
 |
NovaSom is a medical device manufacturer and diagnostic service provider for home testing for the diagnosis of sleep disordered breathing, including Obstructive Sleep Apnea (OSA). |
 |
OncoHealth is developing devices for cervical cancer screening. |
 |
Orlucent is an early stage company working on a diagnostic for melanoma. Orlucent |
 |
Reverse Medical is developing interventional neurovascular devices to improve patient outcomes. |
 |
Relievant Medsystems is designing tools for minimally invasive
treatment of chronic low back pain. Relievant Medsystems |
 |
Transcorp was formed to develop and market minimally invasive
devices for spinal surgery that reduce cost and recovery time. TransCorp Spine |
 |
Satiety was formed to develop devices for less invasive
treatment of obesity, including the TOGA® System for transoral
gastroplasty. Satiety |
 |
Sonoma is developing devices which enable faster and less
invasive fixation of bone fractures. Sonoma Orthopedic Products |
| SP Surgical | SP Surgical was formed to develop a continuous suture passing device for minimally invasive orthopedic shoulder surgery. |
|
Stimwave, Inc. was formed in 2011 for the purpose of developing a wireless device for pain modulation.
Stimwave Technologies |
| Venous Health Systems | Venous Health Systems as formed to develop devices for the treatment of deep vein thrombosis. |
| VivaRay | VivaRay was formed to develop, manufacture and market devices for delivery of brachytherapy treatment in patients with gynecological cancer. The company was acquired by Varian in March 2011. |
 |
 |